DE3050999C2 - Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten - Google Patents

Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten

Info

Publication number
DE3050999C2
DE3050999C2 DE3050999A DE3050999A DE3050999C2 DE 3050999 C2 DE3050999 C2 DE 3050999C2 DE 3050999 A DE3050999 A DE 3050999A DE 3050999 A DE3050999 A DE 3050999A DE 3050999 C2 DE3050999 C2 DE 3050999C2
Authority
DE
Germany
Prior art keywords
isopropylamino
hydroxypyrimidine
medicaments
contain
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3050999A
Other languages
German (de)
English (en)
Other versions
DE3050999A1 (ko
Inventor
André Paris Esanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'etudes De Produits Chimiques Sa Paris Fr Ste
Original Assignee
D'etudes De Produits Chimiques Sa Paris Fr Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3050999(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by D'etudes De Produits Chimiques Sa Paris Fr Ste filed Critical D'etudes De Produits Chimiques Sa Paris Fr Ste
Publication of DE3050999A1 publication Critical patent/DE3050999A1/de
Application granted granted Critical
Publication of DE3050999C2 publication Critical patent/DE3050999C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
DE3050999A 1979-03-10 1980-03-10 Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten Expired DE3050999C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
DE3050999A1 DE3050999A1 (ko) 1985-08-14
DE3050999C2 true DE3050999C2 (de) 1986-08-14

Family

ID=26270867

Family Applications (3)

Application Number Title Priority Date Filing Date
DE3009071A Expired DE3009071C2 (de) 1979-03-10 1980-03-10 2-Isopropylamino-hydroxypyrimidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3050999A Expired DE3050999C2 (de) 1979-03-10 1980-03-10 Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten
DE19803016752 Granted DE3016752A1 (de) 1979-03-10 1980-04-30 Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3009071A Expired DE3009071C2 (de) 1979-03-10 1980-03-10 2-Isopropylamino-hydroxypyrimidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19803016752 Granted DE3016752A1 (de) 1979-03-10 1980-04-30 Verfahren zur herstellung von 2-isopropylaminopyrimidinhydroxy-derivaten

Country Status (24)

Country Link
JP (1) JPS55122768A (ko)
AR (1) AR222691A1 (ko)
AU (1) AU533547B2 (ko)
BE (1) BE881752A (ko)
CA (1) CA1132561A (ko)
CH (1) CH644368A5 (ko)
DE (3) DE3009071C2 (ko)
EG (1) EG14282A (ko)
FI (1) FI66357C (ko)
FR (2) FR2451370A1 (ko)
GB (1) GB2045756B (ko)
HK (1) HK55383A (ko)
IE (1) IE49547B1 (ko)
IN (1) IN153791B (ko)
LU (1) LU82185A1 (ko)
MX (1) MX6218E (ko)
MY (1) MY8400200A (ko)
NL (1) NL184833C (ko)
NO (1) NO154054C (ko)
NZ (1) NZ192927A (ko)
OA (1) OA06484A (ko)
PT (1) PT70882A (ko)
SE (1) SE435180B (ko)
SG (1) SG22683G (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
FR2451370B1 (ko) 1983-05-13
FI66357C (fi) 1984-10-10
DE3009071A1 (de) 1980-09-11
LU82185A1 (fr) 1980-06-06
DE3016752A1 (de) 1980-12-04
HK55383A (en) 1983-11-25
GB2045756B (en) 1983-01-26
MY8400200A (en) 1984-12-31
DE3009071C2 (de) 1985-11-14
GB2045756A (en) 1980-11-05
NL8001289A (nl) 1980-09-12
JPS55122768A (en) 1980-09-20
MX6218E (es) 1984-12-21
IN153791B (ko) 1984-08-18
CA1132561A (en) 1982-09-28
SG22683G (en) 1983-12-16
IE800477L (en) 1980-09-10
NL184833C (nl) 1989-11-16
NL184468B (nl) 1989-03-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
JPS6126996B2 (ko) 1986-06-23
NO800664L (no) 1980-09-11
EG14282A (en) 1983-09-30
FR2451191A1 (fr) 1980-10-10
SE435180B (sv) 1984-09-10
DE3050999A1 (ko) 1985-08-14
NZ192927A (en) 1981-07-13
SE8001812L (sv) 1980-09-11
BE881752A (fr) 1980-05-30
NO154054C (no) 1986-07-09
FI800566A (fi) 1980-09-11
FI66357B (fi) 1984-06-29
AU5624880A (en) 1980-09-18
FR2451370A1 (fr) 1980-10-10
NL184833B (nl) 1989-06-16
AR222691A1 (es) 1981-06-15
OA06484A (fr) 1981-07-31
AU533547B2 (en) 1983-12-01
FR2451191B1 (ko) 1983-04-29
PT70882A (en) 1980-03-01
NO154054B (no) 1986-04-01
DE3016752C2 (ko) 1987-06-25

Similar Documents

Publication Publication Date Title
EP0044088B1 (de) p-Methoxybenzoyl-Derivate
DE3050999C2 (de) Arzneimittel, die 2-Isopropylamino-4-hydroxypyrimidin enthalten
DE2718669C2 (ko)
EP0011237A1 (de) Polyäther-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2707095C3 (de) Isopropylaminopyrimidinorthophosphat
DD284026A5 (de) Verfahren zur herstellung von estern
DE2009685A1 (de) In 1-Stellung substituierte Derivate von 3,4-Dihydrocarbostyril
DE3709552A1 (de) Pharmazeutische zusammensetzungen
DE2711149C3 (de) N-Substituierte[4-Chlor-6-(23-xylidino)-2· pyrimidinyl- thio] essigsäureamide sowie Verfahren zu deren Herstellung
DE3220831A1 (de) N-(2-methoxyethyl)-noroxymorphon, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
CH630058A5 (de) Verfahren zur herstellung von neuen disubstituierten phenolaethern des 3-amino-2-hydroxypropans.
EP0049494B1 (de) Ester von 7-Hydroxylalkyl-1,3-dimethylxanthinen, Verfahren zu ihrer Herstellung und ihre Verwendung als lipidsenkende Mittel
DE2629133C2 (de) 5"-Amino-3',5"-didesoxyribostamycin, Verfahren zu dessen Herstellung sowie antimikrobielle Zubereitungen
DE3116250A1 (de) "nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel"
DE3390386T1 (de) Antitumor-Mittel, Verfahren zur Tumor-Therapie und Verwendung zur Tumor-Therapie
DE1593970C3 (de) Homoargininpolymere und Verfahren zu ihrer Herstellung
DE3239719T1 (de) Uracil-Derivate, Verfahren zu ihrer Herstellung und dieselben enthaltende pharmazeutische Zusammensetzungen
DE2204989C3 (de) 2-Phenyl-3-(beta-dlmethylaminopropionyl)benzoturan und dessen pharmakologisch verträgliche Säureadditionssalze sowie diese Verbindungen enthaltende Arzneimittel
DE3907512C2 (de) Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
DE2133082C3 (de) Q-Methyl-S-benzoyl-e-methoxyindolyl-l)-essigsäureglycerylester, i Verfahren zu deren Herstellung und Arzneimittel
AT329551B (de) Verfahren zur herstellung neuer derivate des n-phenyl-n-alkanoyl-2-aminoindans
DE2416302B2 (de) Dimeres sowie trimeres silybin und deren n-methylglucaminsalz und verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE1695390C3 (de) 8-Azaspiro [4,5 ] decan-7,9-dionderivate

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 3009071

8181 Inventor (new situation)

Free format text: ESANU, ANDRE, PARIS, FR

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 3009071

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee